Endothelial epithelial sodium channel inhibition activates endothelial nitric oxide synthase via phosphoinositide 3-kinase/akt in small-diameter mesenteric arteries

Hypertension

Volumn 53, Issue 6, 2009, Pages 1000-1007

  Pérez, Francisco R ^a,c   Venegas, Fabiola ^a,c   González, Magdalena ^a,b   Andrés, Sergio ^a   Vallejos, Catalina ^a   Riquelme, Gloria ^a   Sierralta, Jimena ^a,b   Michea, Luis ^a,c  

^a UNIVERSITY OF CHILE   (Chile)

^b Centro de Neurociencias Integradas   (Chile)

^c Centro FONDAP Estudios Moleculares de la Celula   (Chile)

Author keywords

Aldosterone; Endothelium derived factors; No synthase

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; AMILORIDE; BENZAMIL; ENDOTHELIAL NITRIC OXIDE SYNTHASE; EPITHELIAL SODIUM CHANNEL; PHENYLEPHRINE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SEROTONIN; DRUG DERIVATIVE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTERY DIAMETER; ARTERY ENDOTHELIUM; ARTICLE; CELL CULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME PHOSPHORYLATION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MESENTERIC ARTERY; NONHUMAN; PATCH CLAMP; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT; SHEAR STRESS; TUNICA MEDIA; WESTERN BLOTTING; ANALYSIS OF VARIANCE; ANIMAL; ANIMAL MODEL; BLOOD FLOW VELOCITY; COMPARATIVE STUDY; DRUG EFFECT; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; PROBABILITY; RANDOMIZATION; SPRAGUE DAWLEY RAT; VASCULAR ENDOTHELIUM;

1-PHOSPHATIDYLINOSITOL 3-KINASE; AMILORIDE; ANALYSIS OF VARIANCE; ANIMALS; BLOOD FLOW VELOCITY; BLOTTING, WESTERN; ENDOTHELIUM, VASCULAR; EPITHELIAL SODIUM CHANNEL; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MESENTERIC ARTERIES; MODELS, ANIMAL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHOSPHORYLATION; PROBABILITY; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 67049155914     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.108.128520     Document Type: Article

References (31)

1. Kellenberger S, Schild L. Epithelial sodium channel/degenerin family of ion channels: a variety of functions for a shared structure. Physiol Rev. 2002;82:735-767.
2. Garty H, Palmer L. Epithelial sodium channels: function, structure, and regulation. Physiol Rev. 1997;77:359-396.
3. Warnock DG, Rossier BC. Renal sodium handling: the role of the epithelial sodium channel. J Am Soc Nephrol. 2005;16:3151-3153.
4. + channel is made of three homologous subunits. Nature. 1994;367:463-467.
5. + channel proteins. Components of a vascular mechanosensor. Hypertension. 2004;44:643-648.
6. Golestaneh N, Klein C, Valamanesh F, Suarez G, Agarwal MK, Mirshahi M. Mineralocorticoid receptor-mediated signaling regulates the ion gated sodium channel in vascular endothelial cells and requires an intact cytoskeleton. Biochem Biophys Res Commun. 2001;280:1300-1306.
7. Oberleithner H, Ludwig T, Riethmüller C, Hillebrand U, Albermann L, Schafer C, Shahin V, Schillers H. Human endothelium: target for aldosterone. Hypertension. 2004;43:952-956.
8. Jernigan NL, Drummond HA. Vascular ENaC proteins are required for renal myogenic constriction. Am J Physiol Renal Physiol. 2005;289: F891-F901.
9. Jernigan NL, Drummond HA. Myogenic vasoconstriction in mouse renal interlobar arteries: role of endogenous beta and gamma ENaC. Am J Physiol Renal Physiol. 2006;291:F1184-F1191.
10. Kusche-Vihrog K, Sobczak K, Bangel N, Wilhelmi M, Nechyporuk-Zloy V, Schwab A, Schillers H, Oberleithner H. Aldosterone and amiloride alter ENaC abundance in vascular endothelium. Pflugers Arch. 2008;455: 849-857.
11. Oberleithner H, Riethmüller C, Schillers H, MacGregor GA, de Wardener HE, Hausberg M. Plasma sodium stiffens vascular endothelium and reduces nitric oxide release. Proc Natl Acad Sci U S A. 2007; 104: 16281-16286.
12. Carattino MD, Sheng S, Kleyman TR. Epithelial Na+ channels are activated by laminar shear stress. J Biol Chem. 2004;279:4120-4126.
13. Michea L, Delpiano AM, Hitschfeld C, Lobos L, Lavandero S, Marusic ET. Eplerenone blocks nongenomic effects of aldosterone on the Na+/H+ exchanger, intracellular Ca2+ levels, and vasoconstriction in mesenteric resistance vessels. Endocrinology. 2005;146:973-980.
14. Gonzalez M, Lobos L, Castillo F, Galleguillos L, Lopez NC, Michea L. High-salt diet inhibits expression of angiotensin type 2 receptor in resistance arteries. Hypertension. 2005;45:853-859.
15. Matrougui K, Maclouf J, Lévy BI, Henrion D. Impaired nitric oxide- and prostaglandin-mediated responses to flow in resistance arteries of hypertensive rats. Hypertension. 1997;30:942-947.
16. Rahman A, Matchkov V, Nilsson H, Aalkjaer C. Effects of cGMP on coordination of vascular smooth muscle cells of rat mesenteric small arteries. J Vasc Res. 2005;42:301-311.
17. Masilamani S, Kim G, Mitchell C, Wade JB, Knepper MA. Aldosterone-mediated regulation of ENaC α, β and γ subunit proteins in rat kidney. J Clin Invest. 1999;104:R19-R23.
18. Snead MD, Papapetropoulos A, Carrier GO, Catravas D. Isolation and culture of endothelial cells from the mesenteric vascular bed. Methods Cell Sci. 1995;17:257-262.
19. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch. 1981;391:85-100.
20. McCabe TJ, Fulton D, Roman LJ, Sessa WC. Enhanced electron flux and reduced calmodulin dissociation may explain "calcium-independent" eNOS activation by phosphorylation. J Biol Chem. 2000;275:6123-6128.
21. Traub O, Berk BC. Laminar shear stress: mechanisms by which endothelial cells transduce an atheroprotective force. Arterioscler Thromb Vasc Biol. 1998;18:677-685.
22. Chatzizisis YS, Coskun AU, Jonas M, Edelman ER, Feldman CL, Stoneet PH. Role of endothelial shear stress in the natural history of coronary atherosclerosis and vascular remodeling: molecular, cellular, and vascular behavior. J Am Coll Cardiol. 2007;49:2379-2393.
23. Boo YC, Jo H. Flow-dependent regulation of endothelial nitric oxide synthase: role of protein kinases. Am J Physiol, Cell Physiol. 2003;285: C499-C508.
24. Govers R, Rabelink TJ. Cellular regulation of endothelial nitric oxide synthase. Am J Physiol Renal Physiol. 2001;280:F193-F206.
25. Miura H, Wachtel RE, Liu Y, Loberiza FR Jr, Saito T, Miura M, Gutterman DD. Flow-induced dilation of human coronary arterioles: important role of Ca(2+)-activated K(+) channels. Circulation. 2001; 103:1992-1998.
26. Funder J. Aldosterone, mineralocorticoid receptors and vascular inflammation. Mol Cell Endocrinol. 2004;217:263-269.
27. Nagata D, Takahashi M, Sawai K, Tagami T, Usui T, Shimatsu A, Hirata Y, Naruse M. Molecular mechanism of the inhibitory effect of aldosterone on endothelial NO synthase activity. Hypertension. 2006;48: 165-171.
28. Schiffrin EL. Effects of aldosterone on the vasculature. Hypertension. 2006;47:312-318.
29. Farquharson CAJ, Struthers AD. Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I/angiotensin II conversion in patients with chronic heart failure. Circulation. 2000;101:594-597.
30. Bauersachs J, Heck M, Fraccarollo D, Hildemann SK, Ertl G, Wehling M, Christ M. Addition of spironolactone to angiotensin-converting enzyme inhibition in heart failure improves endothelial vasomotor dysfunction: role of vascular superoxide anion formation and endothelial nitric oxide synthase expression. J Am Coll Cardiol. 2002;39:351-358.
31. Sartório CL, Fraccarollo D, Galuppo P, Leutke M, Ertl G, Stefanon I, Bauersachs J. Mineralocorticoid receptor blockade improves vasomotor dysfunction and vascular oxidative stress early after myocardial infarction. Hypertension. 2007;50:919-925.